MENU
ORKA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Oruka Therapeutics (ORKA) Earnings Date & Reports
Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications... Show more
A.I. Advisor
published Earnings
ORKA is expected to report earnings to rise 23.64% to -68 cents per share on November 11
Q3'26
Est.
$-0.68
Q2'26
Missed
by $0.04
Q4'25
Beat
by $0.27
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.20
The last earnings report on August 10 showed earnings per share of -55 cents, missing the estimate of -50 cents. With 429.65K shares outstanding, the current market capitalization sits at 6.71B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
855 Oak Grove Avenue
Phone
+1 650 606-7910
Employees
68
Web
https://www.orukatx.com